Scopus BioPharma Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
12.00
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
0.00
|
0.00
|
0.00
|
0.00%
|
|
2022-09-30
|
0.00
|
-0.09
|
-0.09
|
0.00%
|
|
2022-06-30
|
0.00
|
-0.16
|
0.00
|
0.00%
|
|
2022-03-31
|
0.00
|
-0.22
|
0.00
|
0.00%
|
|
2021-12-31
|
-0.07
|
-0.07
|
0.00
|
0.00%
|
|
2021-09-30
|
-0.23
|
-0.08
|
0.15
|
65.22%
|
|
2021-06-30
|
-0.23
|
-0.97
|
-0.74
|
-321.74%
|
|
2021-03-31
|
-0.08
|
-0.22
|
-0.14
|
-175.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.47
|
|
2021-12-31
|
-1.34
|
|
2020-12-31
|
-0.56
|
|
2019-12-31
|
-0.52
|
|
2018-12-31
|
-0.10
|
|
2017-12-31
|
-0.01
|